论文部分内容阅读
目的:对福州市新生儿疾病筛查情况进行成本-效益分析,探讨新生儿疾病筛查的社会经济效益。方法:回顾性分析2013年福州市新生儿疾病筛查结果,将调查所得数据与福州市经济数据相结合,计算福州市新生儿疾病筛查的成本和效益。结果:福州市开展新生儿疾病筛查净效益为10 227.88万元,新生儿先天性甲状腺机能减低症(CH)筛查成本-效益比为1∶18.90,苯丙酮尿症(PKU)筛查成本-效益比为1∶2.38,葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症筛查成本-效益比为1∶84.51,先天性肾上腺皮质增生症(CAH)筛查成本-效益比为1∶3.36。结论:福州市新生儿疾病筛查工作具有良好的社会经济效益,值得推广应用。
OBJECTIVE: To carry out a cost-benefit analysis of neonatal screening in Fuzhou to explore the social and economic benefits of neonatal screening. Methods: A retrospective analysis of screening results of neonatal diseases in Fuzhou City in 2013 was conducted. The data obtained from the survey and the economic data of Fuzhou City were combined to calculate the cost and benefit of neonatal screening in Fuzhou. Results: The net benefit of neonatal screening in Fuzhou was RMB 10,278,800 and the cost-benefit ratio of neonatal congenital hypothyroidism (CH) screening was 1:18.90. The cost of screening for phenylketonuria (PKU) - benefit ratio of 1: 2.38, cost-benefit ratio of glucose-6-phosphate dehydrogenase (G6PD) screening of 1:84.51, and cost-benefit ratio of screening for congenital adrenal hyperplasia (CAH) 3.36. Conclusion: The screening of neonatal diseases in Fuzhou has good social and economic benefits and is worth popularizing and applying.